November 2, 2012
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs at a meeting on October 31 discussed and recommended approval for additional indications of renal angiomyolipoma and subependymal giant-cell astrocytomas (SEGA) associated with tuberous sclerosis for Novartis Pharma’s...read more